We serve Chemical Name:Verdyl propionate CAS:68912-13-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Verdyl propionate
CAS.NO:68912-13-0
Synonyms:Dicyclopentadiene propionate;4,7-Methano-1H-indenol,3a,4,5,6,7,7a-hexahydro-,propanoate;3a,4,5,6,7,7a-Hexahydro-4,7-methano-1H-indenyl propionate;EINECS 272-805-7
Molecular Formula:C13H18O2
Molecular Weight:206.28100
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:276.2ºC at 760 mmHg
Density:1.1g/cm3
Index of Refraction:1.531
PSA:26.30000
Exact Mass:206.13100
LogP:2.54030
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Dicyclopentadiene propionate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 272-805-7 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,7-Methano-1H-indenol,3a,4,5,6,7,7a-hexahydro-,propanoate Use and application,Dicyclopentadiene propionate technical grade,usp/ep/jp grade.
Related News: However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future. Verdyl propionate manufacturer A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643). Verdyl propionate supplier A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643). Verdyl propionate vendor The Big Pharma had, however, decided to all but shelve donanemab in the near term as it couldn’t see a regulatory path forward. Verdyl propionate factory A key publication in a preclinical model demonstrated rigosertib��s ability to block cellular signaling by targeting RAS effector pathways (Divakar, S.K., et al., 2016: ��A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block Signaling.�� Cell 165, 643).
